Blosozumab (LY2541546)

Blosozumab · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Blosozumab (LY2541546), covering 2018-07-16 to 2018-07-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants [Phase 1]